The collapse from a trailing to a forward P/E implies the market is pricing a substantial earnings recovery, and the PEG of 7.20 suggests the growth required to justify the current price is steep. Against peers such as JBL at 40.39 and CLS at 28.35 on trailing P/E, BHE screens cheaper on forward earnings, though the forward multiple still sits above the peer group's low-single-digit price-to-book profile. Investors should monitor whether reported quarterly net income converges toward the level implied by the forward estimate.

The stability of gross margin indicates limited pricing power typical of contract manufacturing, so improvement must come from operating leverage, which has been modest with operating margin moving only from 3.5% to 5.1%. The sharp swings in net margin, including 0.2% in 2025Q2, suggest non-operating or tax items are influencing reported earnings more than core operations. Operating margin is therefore the better gauge of underlying earning power for this business.

Returns on capital remain thin across the ten quarters, which suggests the company is not yet compounding capital efficiently despite revenue re-accelerating. The gap between ROE and ROIC is narrow because leverage is low, meaning equity returns are essentially a reflection of weak operating returns rather than financial engineering. Sustained improvement would require net margin expansion in addition to asset turnover gains, which have held around 0.30 to 0.36.

The decline in D/E alongside rising interest coverage suggests the capital structure is strengthening, with reduced refinancing pressure implied by the lower absolute debt load. However, debt-to-EBITDA of 6.26 remains elevated relative to the leverage metrics implied by the equity ratio, indicating the low D/E is partly a function of a large equity base against thin earnings. Investors should monitor whether EBITDA recovery sustains coverage if the forward earnings improvement is delayed.